Citigroup Maintains Buy on Xylem, Lowers Price Target to $148
Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $172 to $148.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga